1998
DOI: 10.1016/s1368-8375(97)00052-3
|View full text |Cite
|
Sign up to set email alerts
|

Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
51
1
2

Year Published

1999
1999
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 85 publications
(56 citation statements)
references
References 12 publications
2
51
1
2
Order By: Relevance
“…The identification of molecular genetic activity detects lesions that may become malignant. This facilitates the clinical intervention and prevents surgical injuries (16). The expression of p53 may be associated with the development of OSCC and dysplasia, being more evident in the early stages of carcinogenesis (17) due to the lack of apoptosis and the continuous Table I.…”
Section: Discussionmentioning
confidence: 99%
“…The identification of molecular genetic activity detects lesions that may become malignant. This facilitates the clinical intervention and prevents surgical injuries (16). The expression of p53 may be associated with the development of OSCC and dysplasia, being more evident in the early stages of carcinogenesis (17) due to the lack of apoptosis and the continuous Table I.…”
Section: Discussionmentioning
confidence: 99%
“…19 Arguments against this vision arise from studies showing high MSI incidences in pre-malignant lesions and in young patients. 20,24 Most studies report on a lack of MMR gene defects in HNSCC compared with HNPCC. 14,21,24,29 This could either indicate a low incidence of MSI or a higher proportion of non-MMR MSI cases.…”
Section: What Are Msi and Loh?mentioning
confidence: 99%
“…Loss of heterozygosity (LOH) studies using microsatellite markers on head-and-neck malignancies have demonstrated extensive areas of loss. [1][2][3][4][5] Moreover, premalignant lesions studied in the initial description of a genetic progression model revealed the timing of genetic alterations such as LOH as premalignant lesions advance toward malignancy. 6 These specific genetic events can be detected in the saliva and serum of patients with head and neck malignancy, 7,8 opening the door to new strategies for early cancer detection and tumor surveillance.…”
mentioning
confidence: 99%